NCT00186108View on ClinicalTrials.gov

A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

September 30, 2005

Conditions
Prostate Cancer
Interventions
DRUG

Oral Triamcinalone

Trial Locations (1)

94305

Stanford University Cancer Center, Stanford

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Stanford University

OTHER

NCT00186108 - A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer | Biotech Hunter | Biotech Hunter